Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M Estimate

Author: Benzinga Newsdesk | May 09, 2024 04:30pm
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $74.723 million which missed the analyst consensus estimate of $74.802 million by 0.10 percent. This is a 1.16 percent increase over sales of $73.868 million the same period last year.

Posted In: HCAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist